Adagrasib,Cetuximab,Afatinib,Pembrolizumab
Eli Lilly,Boehringer Ingelheim,Merck,Mirati Therapeutics
[]
cracking krasg12c across all solid tumors: the new kid on the block for tissue-agnostic precision medicine - esmo open 
Associate Scientific Director, Computational Biology Oncology at @boehringer 🧬 Data Scientist & KRAS, MDM2 , HER2 Research. Tweets are my own.